1.0099
+0.0133
+(1.33%)
As of 3:04:17 PM EDT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
64.6560
29.8160
72.8550
339.6660
--
Cost of Revenue
543.3900
331.0800
853.3360
376.7870
126.7990
Gross Profit
-478.7340
-301.2640
-780.4810
-37.1210
-126.7990
Operating Expense
9,493.8170
11,677.2540
13,872.4640
11,947.8540
3,978.4470
Operating Income
-9,972.5510
-11,978.5180
-14,652.9450
-11,984.9750
-3,978.4470
Net Non Operating Interest Income Expense
-146.4450
293.4120
384.8000
-46.5390
-2.3530
Other Income Expense
-538.6300
-118.6680
-146.1210
-19,662.5340
112.1500
Pretax Income
-10,657.6260
-11,803.7740
-14,414.2660
-31,694.0480
-3,868.6500
Tax Provision
--
-99.7840
--
--
--
Net Income Common Stockholders
-10,657.6260
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
Diluted NI Available to Com Stockholders
-10,657.6260
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
Basic EPS
-0.11
-0.12
-0.14
-0.34
-0.05
Diluted EPS
-0.11
-0.12
-0.14
-0.34
-0.05
Basic Average Shares
102,128.1100
100,503.4420
99,436.2640
92,091.9830
84,022.4240
Diluted Average Shares
102,128.1100
100,503.4420
99,436.2640
92,091.9830
84,022.4240
Total Operating Income as Reported
--
--
--
-12,562.6650
-4,313.7200
Rent Expense Supplemental
307.3720
359.6510
362.3710
196.9940
51.5700
Total Expenses
10,037.2070
12,008.3340
14,725.8000
12,324.6410
3,978.4470
Net Income from Continuing & Discontinued Operation
-10,657.6260
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
Normalized Income
-10,650.4370
-11,548.7822
-14,270.1600
-12,022.1130
-3,868.6500
Interest Income
157.7310
405.4830
510.2570
20.5970
4.1070
Interest Expense
299.4200
107.3730
120.6240
63.7770
6.4600
Net Interest Income
-146.4450
293.4120
384.8000
-46.5390
-2.3530
EBIT
-10,358.2060
-11,696.4010
-14,293.6420
-31,630.2710
-3,862.1900
EBITDA
-9,736.8360
-11,082.6870
-13,753.9490
-31,015.5610
-3,735.3910
Reconciled Cost of Revenue
543.3900
331.0800
853.3360
376.7870
126.7990
Reconciled Depreciation
621.3700
613.7140
539.6930
614.7100
126.7990
Net Income from Continuing Operation Net Minority Interest
-10,657.6260
-11,703.9900
-14,414.2660
-31,694.0480
-3,868.6500
Total Unusual Items Excluding Goodwill
-7.1890
-156.5310
-144.1060
-19,671.9350
--
Total Unusual Items
-7.1890
-156.5310
-144.1060
-19,671.9350
--
Normalized EBITDA
-9,729.6470
-10,926.1560
-13,609.8430
-11,343.6260
-3,735.3910
Tax Rate for Calcs
--
0
--
--
--
Tax Effect of Unusual Items
--
-1.3232
--
--
--
3/31/2021 - 4/2/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AQA.F Advanced Medical Solutions Group plc
2.2000
-5.17%
1358.HK PW MEDTECH
0.990
0.00%
BOX.SG Becton, Dickinson and Co
178.75
-6.88%
HRAL Hear AtLast Holdings, Inc.
0.0005
+25.00%
SKANz.XC
ALCz.XC
0A0D.IL Alcon Inc.
72.58
-0.78%
BNGO.MX Bionano Genomics, Inc.
66.00
+3.19%
SKAN.SW SKAN Group AG
61.10
+0.99%
SYNSAM.ST Synsam AB (publ)
43.10
+1.29%